Chartwell Investment Partners’s AtriCure ATRC Stock Holding History

Chartwell Investment Partners’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20,590	Closed	-$913K	–	409
2022 Q4	$913K	Buy	20,590 +1,174	+6%	+$49K	0.04%	351
2022 Q3	$759K	Buy	19,416 +5,272	+37%	+$241K	0.03%	364
2022 Q2	$578K	Buy	14,144 +353	+3%	+$16.7K	0.02%	390
2022 Q1	$906K	Buy	13,791 +576	+4%	+$37.3K	0.03%	386
2021 Q4	$919K	Sell	13,215 -407	-3%	-$29.6K	0.03%	389
2021 Q3	$947K	Hold	13,622	–	–	0.03%	381
2021 Q2	$1.08M	Buy	13,622 +129	+1%	+$9.38K	0.03%	369
2021 Q1	$884K	Sell	13,493 -724	-5%	-$44.6K	0.03%	369
2020 Q4	$791K	Sell	14,217 -3,226	-18%	-$139K	0.03%	373
2020 Q3	$696K	Hold	17,443	–	–	0.03%	374
2020 Q2	$784K	Sell	17,443 -6,369	-27%	-$277K	0.03%	350
2020 Q1	$800K	Buy	+23,812	New	+$856K	0.04%	336

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Chartwell Investment Partners's ATRC Position: Q1 2023 in Review

Chartwell Investment Partners sold out of AtriCure (ATRC) in Q1 2023, closing a stake of 20,590 shares — an estimated $913K sold.

Chartwell Investment Partners first reported a position in ATRC in Q1 2020 and held it in 12 quarters. The position peaked at $1.08M in Q2 2021. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2023.

Chartwell Investment Partners reported no remaining AtriCure position as of Q1 2023 after selling out during the quarter.
Chartwell Investment Partners sold 20,590 AtriCure shares in Q1 2023, an estimated $913K.
Chartwell Investment Partners first reported a position in AtriCure in Q1 2020 and held it in 12 quarters.
Chartwell Investment Partners's AtriCure position peaked at $1.08M in Q2 2021.
224 funds tracked by Wall St. Rank held AtriCure as of Q1 2023.

Based on Chartwell Investment Partners's 13F filing for Q1 2023, filed 14 Apr 2023.